|
|
Exemptions from the restrictions on the sale and supply of prescription only medicines
|
|
Column 1
|
Column 2
|
Column 3
|
Column 4
|
Column 5
|
|
Substance
|
Maximum strength
|
Route of
administration,
use or
pharmaceutical
form
|
Treatment limitations
|
Maximum quantity
|
|
Hexamine Phenylcinchoninate |
|
|
|
|
|
Hexobarbitone |
|
|
|
|
|
Hexobarbitone Sodium |
|
|
|
|
|
Hexoestrol |
|
|
|
|
|
Hexoestrol Dipropionate |
|
|
|
|
|
L-Histidine Hydrochloride |
|
Dietary supplementation |
|
|
|
Homatropine |
|
(1) Internal |
(1) 0.15mg (MD) |
|
|
|
|
|
0.45mg (MDD) |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Homatropine Hydrobromide |
|
|
0.2mg (MD) |
|
|
|
|
|
0.6mg (MDD) |
|
|
Homatropine Methylbromide |
|
|
2mg (MD) |
|
| |
|
|
6mg (MDD) |
|
|
Hydralazine Hydrochloride |
|
|
|
|
|
Hydrargaphen |
|
Local application to skin |
|
|
|
Hydrobromic Acid |
|
|
|
|
|
Hydrochlorothiazide |
|
|
|
|
|
Hydrocortisone |
1.0 per cent |
External |
|
Container or package containing not more than 15g of medicinal product (cream or ointment) or 30ml (spray) |
|
|
|
For use either alone or in conjunction with Crotamiton in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and either in combination with Clotrimazole for athlete's foot and candidal intertrigo or in combination with lignocaine for anal and perianal itch associated with haemorrhoids |
|
|
|
|
|
For use in adults and children not less than 10 years |
|
|
|
|
|
Cream ointment or spray |
|
|
|
Hydrocortisone Acetate |
Equivalent to 1.0 per cent Hydrocortisone |
External |
|
|
|
|
|
For use in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and in combination with one or more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgallate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for haemorrhoids |
|
Container or package containing not more than 15g of medicinal product |
|
|
|
|
|
In the case of suppositories, container or package containing no more than 12 |
|
|
|
For use in adults and children not less than 10 years |
|
|
|
|
|
Cream, ointment or suppositories |
|
|
|
Hydrocortisone Butyrate |
|
|
|
|
|
Hydrocortisone Caprylate |
|
|
|
|
|
Hydrocortisone Hydrogen Succinate |
|
|
|
|
|
Hydrocortisone Sodium Phosphate |
|
|
|
|
|
Hydrocortisone Sodium Succinate |
Equivalent to 2.5mg Hydrocortisone |
External |
|
Container or package containing not more than equivalent to 50mg of Hydrocortisone |
|
|
|
For aphthous ulceration of the mouth for adults and children not less than 12 years |
|
|
|
|
|
In the form of pellets |
|
|
|
Hydroflumethiazide |
|
|
|
|
|
Hydroxychloroquine Sulphate |
|
Prophylaxis of malaria |
|
|
|
Hydroxyprogesterone |
|
|
|
|
|
Hydroxyprogesterone Enanthate |
|
|
|
|
|
Hydroxyprogesterone Hexanoate |
|
|
|
|
|
Hydroxyurea |
|
|
|
|
|
Hydroxyzine Embonate |
|
|
|
|
|
Hydroxyzine Hydrochloride |
|
(a) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in adults and in children not less than 12 years |
(a) 25mg (MD) |
(a) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride |
|
|
|
|
75mg (MDD) |
|
|
|
|
(b) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in children not less than 6 years but less than 12 years |
(b) 25 mg (MD) |
(b) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride |
|
|
|
|
50mg (MDD) |
|
|
Hyoscine |
(1) 0.15 per cent |
(1) Internal |
|
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Hyoscine Butylbromide |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 20mg (MD)
80mg (MDD) |
(b) Container or package containing not more than 240mg of Hyoscine Butylbromide |
|
|
|
(2) External |
|
|
|
Hyoscine Hydrobromide |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 300mcg (MD) |
|
|
|
|
|
900mcg (MDD) |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Hyoscine Methobromide |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 2.5mg (MD) |
|
|
|
|
|
7.5mg (MDD) |
|
|
|
|
(2) External |
|
|
|
Hyoscine Methonitrate |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 2.5mg (MD) |
|
|
|
|
|
7.5mg (MDD) |
|
|
|
|
(2) External |
|
|
|
Hyoscyamine |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 300mcg (MD) |
|
|
|
|
|
1mg (MDD) |
|
|
|
|
(2) External |
|
|
|
Hyoscyamine Hydrobromide |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) Equivalent of 300mcg of Hyoscyamine (MD) |
|
|
|
|
|
Equivalent of 1mg of Hyoscyamine (MDD) |
|
|
|
|
(2) External |
|
|
|
Hyoscyamine Sulphate |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) Equivalent of 300mcg of Hyoscyamine (MD) |
|
|
|
|
|
Equivalent of 1mg of Hyoscyamine (MDD) |
|
|
|
|
(2) External |
|
|
|
Ibuprofen |
|
Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza |
|
|
|
|
|
(1) Internal |
(1)(a) In the case of a prolonged release preparation 600mg (MD) |
|
|
|
|
|
1,200mg (MDD) |
|
|
|
|
|
(b) in any other case 400mg (MD) |
|
|
|
|
|
1,200mg (MDD) |
|
|
|
(2) 5.0 per cent |
(2) External |
|
|
|
Idarubicin Hydrochloride |
|
|
|
|
|
Idoxuridine |
|
|
|
|
|
Ifosfamide |
|
|
|
|
|
Ignatius Bean |
|
|
|
|
|
Imipenem Hydrochloride |
|
|
|
|
|
Imipramine |
|
|
|
|
|
Imipramine Hydrochloride |
|
|
|
|
|
Imipramine Ion Exchange Resin Bound Salt or Complex |
|
|
|
|
|
Indapamide Hemihydrate |
|
|
|
|
|
Indomethacin |
|
|
|
|
|
Indomethacin Sodium |
|
|
|
|
|
Indoprofen |
|
|
|
|
|
Indoramin Hydrochloride |
|
|
|
|
|
Inosine Pranobex |
|
|
|
|
|
Iodamide |
|
|
|
|
|
Iodamide Meglumine |
|
|
|
|
|
Iodamide Sodium |
|
|
|
|
|
Iohexol |
|
|
|
|
|
Iomeprol |
|
|
|
|
|
Iopamidol |
|
|
|
|
|
Iopentol |
|
|
|
|
|
Iothalamic Acid |
|
|
|
|
|
Ioversol |
|
|
|
|
|
Ioxaglic Acid |
|
|
|
|
|
Ipratropium Bromide |
|
|
|
|
|
Iprindole Hydrochloride |
|
|
|
|
|
Iproniazid Phosphate |
|
|
|
|
|
Isoaminile |
|
|
|
|
|
Isoaminile Citrate |
|
|
|
|
|
Isocarboxazid |
|
|
|
|
|
Isoconazole Nitrate |
|
External but in the case of vaginal use only external use for the treatment of vaginal candidiasis |
|
|
|
Isoetharine |
|
|
|
|
|
Isoetharine Hydrochloride |
|
|
|
|
|
Isoetharine Mesylate |
|
|
|
|
|
Isoniazid |
|
|
|
|
|
Isoprenaline Hydrochloride |
|
|
|
|
|
Isoprenaline Sulphate |
|
|
|
|
|
Isopropamide Iodide |
|
|
Equivalent of 2.5mg of Isopropamide ion (MD) |
|
|
|
|
|
Equivalent of 5.0mg of Isopropamide ion (MDD) |
|
|
Isotretinoin |
|
|
|
|
|
Isradipine |
|
|
|
|
|
Itraconazole |
|
|
|
|
|
Jaborandi |
|
External |
|
|
|
Kanamycin Acid Sulphate |
|
|
|
|
|
Kanamycin Sulphate |
|
|
|
|
|
Ketamine Hydrochloride |
|
|
|
|
Other UK SIs |
Home |
National Assembly for Wales Statutory Instruments |
Scottish Statutory Instruments |
Statutory Rules of Northern Ireland |
Her Majesty's Stationery Office